Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | Mammaglobin-A |
| Synonyms | |
| Therapy Description |
Mammaglobin-A (MAM-A) is a DNA-vaccine, which potentially induces cytotoxic immune response and antitumor activity against tumor cells over expressing MAM-A (PMID: 25451106, PMID: 22678162). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| Mammaglobin-A | MAM-A | Mammaglobin-A (MAM-A) is a DNA-vaccine, which potentially induces cytotoxic immune response and antitumor activity against tumor cells over expressing MAM-A (PMID: 25451106, PMID: 22678162). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT02204098 | Phase I | Mammaglobin-A | Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy | Active, not recruiting | USA | 0 |